An Open label pilot clinical trial to evaluate the effectiveness of SoothagaMezhugu in the management of Soothaga Vaayu (Poly Cystic Ovarian Syndrome) - NI

il0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年6月24日

试验速览

暂无简介。

•Participants must meet the diagnostic criteria for Polycystic Ovary Syndrome (PCOS) as per Rotterdam criteria.
•Women of reproductive age, typically between 18 to 35 years old, should be included.
•Non-pregnant participants or those not actively seeking pregnancy should be included.
•Participants must demonstrate willingness and ability to comply with study requirements, including attending study visits, adhering to treatment protocols, and providing informed consent.

•Pregnant women or those actively trying to conceive.
•Women who have reached menopause or are in the perimenopausal period.
•Hypothyroidism patients.
•Participants with significant medical conditions (e.g., uncontrolled diabetes, cardiovascular disease, severe liver or kidney dysfunction).
•Participants currently using hormonal medications such as oral contraceptives, hormonal replacement therapy, or anti-androgenic medications should be excluded.
•Participants with a history of ovarian surgery.
•Participants currently enrolled in other clinical trials.
•Individuals lacking the capacity to provide informed consent.

发起方